GOLDBERG Y. PAUL

CIK 00016199601 companyBURNABY, A1

SEC Profile

Transactions

Companies

Filings

CIK

0001619960

Recent Transactions

41 trades

Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-10-23+11,000→ 11,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2017-03-13+27,500→ 27,500 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2016-03-11+20,000→ 20,000 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-12-18+15,000→ 15,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-24$8.60/sh−12,000→ 6,000 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-23$9.02/sh−4,000→ 18,000 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−1,829→ 16,448 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.52/sh+3,703→ 20,151 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−7,973→ 4,372 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−785→ 243 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−1,098→ 19,053 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−923→ 21,245 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$2.68/sh+7,973→ 29,218 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−6,172→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−3,115→ 1,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.07/sh+5,144→ 13,630 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.73/sh+3,115→ 22,168 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−3,703→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$5.22/sh+411→ 6,514 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−610→ 7,763 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−411→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−5,144→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$2.68/sh+785→ 28,316 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−167→ 28,149 total
Sale
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.33/sh−6,149→ 22,000 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-09-22−1,028→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.21/sh+2,057→ 8,373 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−1,687→ 27,531 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−198→ 6,316 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.77/sh+1,028→ 8,791 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−305→ 8,486 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$9.53/sh−1,525→ 12,105 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-09-22$3.56/sh+6,172→ 18,277 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$4.81/sh+1,028→ 5,348 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$11.00/sh−434→ 4,914 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-08-18−1,028→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-08-18−2,057→ 0 total
Exercise/Conversion
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$4.98/sh+2,057→ 6,971 total
Tax Payment
Xenon Pharmaceuticals Inc.$XENE
Common Shares
2015-08-18$11.00/sh−868→ 6,103 total
Award
Xenon Pharmaceuticals Inc.$XENE
Stock Option (Right to Buy)
2015-03-17+35,000→ 35,000 total

Companies

Xenon Pharmaceuticals Inc.
VP of Clinical Development
$XENE

Recent Filings

Address

C/O XENON PHARMACEUTICALS INC. 200 - 3650 GILMORE WAY

BURNABY, A1, V5G 4W8

View on SEC.gov